Sieper, Joachim
Braun, Jürgen
Dougados, Maxime
Baeten, Dominique
Article History
First Online: 9 July 2015
Competing interests
: J.S. has received honoraria for being a member of speaker's bureau and/or consulting fees from the following companies: AbbVie Boehringer Ingelheim Janssen Lilly Merck Novartis Pfizer and UCB; and research grants from the following companies: AbbVie Janssen Merck and Pfizer. J.B. discloses no financial conflicts. M.D. has received honouraria for being a member of speaker's bureau and/or consulting fees from the following companies: AbbVie Boehringer Ingelheim Janssen Lilly Merck Novartis Pfizer and UCB; and his department has received research grants from the following companies: AbbVie Janssen Lilly Merck Pfizer Novartis and UCB. D.B. has received honouraria for being a member of speakers bureau and/or consulting fees from the following companies: AbbVie Pfizer MSD UCB Novartis Lilly Boehringer Ingelheim Roche Bristol–Myers Squibb Janssen Glenmark Zymetech and FivePrime.